Pioglitazone safe and effective for treating T2DM in patients with NASH

被引：0
作者：
Tim Geach
机构：
来源：
Nature Reviews Endocrinology | 2016年 / 12卷 / 9期
关键词：
D O I：
10.1038/nrendo.2016.113
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：498 / 498
相关论文
共 50 条
[41]   ADA goals are attainable in patients with T2DM [J].
Hood, Robert C. .
DIABETES, 2006, 55 :A271-A271
[42]   NAFLD prevalence in older patients with T2DM [J].
Eleni Kotsiliti .
Nature Reviews Gastroenterology & Hepatology, 2023, 20 :65-65
[43]   Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Pioglitazone with or without Metformin in Patients with Type 2 Diabetes (T2DM) [J].
Kovacs, Christopher Simon ;
Seshiah, Veeraswamy ;
Merker, Ludwig ;
Christiansen, Anita Vedel ;
Roux, Flavien ;
Salsali, Afshin ;
Kim, Gabriel ;
Stella, Peter ;
Woerle, Hans-Juergen ;
Broedl, Uli C. .
ENDOCRINE REVIEWS, 2014, 35 (03)
[44]   Duration of Depressive Disorders in Patients with T2DM [J].
De Groot, Mary K. ;
Crick, Kent ;
Long, Molly ;
Shubrook, Jay .
DIABETES, 2016, 65 :A217-A217
[45]   SYSTEMATIC REVIEW OF COST EFFECTIVENESS OF DAPAGLIFLOZIN TREATING PATIENTS OF TYPE 2 DIABETES MELLITUS (T2DM) [J].
Hu, C. ;
Zhang, C. ;
Wang, B. ;
Xu, L. .
VALUE IN HEALTH, 2018, 21 :S39-S39
[46]   Pioglitazone (PIO) improves glycemic control in drug-therapy naive patients with type 2 diabetes (T2DM) [J].
Herz, M ;
Tan, M ;
Johns, D ;
Robertson, KE ;
Gonzalez, B ;
Reviriego, J ;
Grossman, L .
DIABETES, 2002, 51 :A481-A481
[47]   Pioglitazone (PIO) improves atherogenic dyslipidemia in drug-therapy naive patients with type 2 diabetes (T2DM) [J].
Tan, MH ;
Herz, M ;
Johns, D ;
Robertson, KE ;
Gonzalez, B ;
Reviriego, J ;
Grossman, LD .
DIABETES, 2002, 51 :A497-A497
[48]   Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM) [J].
Kovacs, Christopher ;
Seshiah, Veeraswamy ;
Swallow, Ros ;
Jones, Russell ;
Rattunde, Henning ;
Woerle, Hans J. ;
Broedl, Uli C. .
DIABETES, 2013, 62 :A291-A291
[49]   Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Pioglitazone With or Without Metformin in Patients with Type 2 Diabetes (T2DM) [J].
Kovacs, Christopher S. ;
Seshiah, Veeraswamy ;
Merker, Ludwig ;
Christiansen, Anita Vedel ;
Roux, Flavien ;
Salsali, Afshin ;
Kim, Gabriel ;
Stella, Peter ;
Woerle, Hans J. ;
Broedl, Uli C. .
DIABETES, 2014, 63 :A273-A273
[50]   Effects of Extended Pioglitazone Treatment (PIO) on Bone Metabolism in Patients with Prediabetes and Type 2 Diabetes Mellitus (T2DM) [J].
Sanchez, Paola Portillo ;
Bril, Fernando ;
Lomonaco, Romina ;
Maximos, Maryann ;
Bruder, Jan ;
Orsak, Beverly ;
Hecht, Joan ;
Cusi, Kenneth .
DIABETES, 2014, 63 :A293-A294
12345